China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,555 | 7,258 | 11,980 | 8,780 | 4,300 |
| Depreciation Amortization | 3,340 | 1,598 | 1,140 | 990 | 630 |
| Accounts receivable | -1,052 | -309 | 82 | N/A | N/A |
| Accounts payable and accrued liabilities | -51 | -253 | -377 | N/A | N/A |
| Other Working Capital | 4,357 | -2,180 | 1,310 | 1,230 | -830 |
| Other Operating Activity | 3,280 | 969 | 5,885 | 3,690 | 2,520 |
| Operating Cash Flow | $28,430 | $7,082 | $20,020 | $14,690 | $6,620 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,866 | -987 | -3,960 | -3,260 | -2,270 |
| Net Acquisitions | 1,570 | 11,939 | 0 | 0 | 0 |
| Purchase Sale Intangibles | -1,015 | -89 | -83 | N/A | N/A |
| Other Investing Activity | -1,605 | -564 | -17,700 | -1,470 | -10 |
| Investing Cash Flow | $-1,901 | $10,389 | $-21,660 | $-4,730 | $-2,280 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 22,485 | 7,648 | 29 | N/A | N/A |
| Debt Issued | -5,863 | N/A | 5,766 | N/A | N/A |
| Debt Repayment | -2,653 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | -280 | -280 | -280 |
| Other Financing Activity | 114 | 0 | -735 | -1,060 | -710 |
| Financing Cash Flow | $14,083 | $7,648 | $4,780 | $-1,340 | $-990 |
| Exchange Rate Effect | 53 | 73 | 660 | 590 | 410 |
| Beginning Cash Position | 8,815 | 8,815 | 5,010 | 5,010 | 5,010 |
| End Cash Position | 49,479 | 34,006 | 8,810 | 14,220 | 8,770 |
| Net Cash Flow | $40,664 | $25,191 | $3,800 | $9,210 | $3,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,430 | 7,082 | 20,020 | 14,690 | 6,620 |
| Capital Expenditure | -1,866 | -987 | -4,034 | N/A | N/A |
| Free Cash Flow | 26,564 | 6,096 | 15,986 | 14,690 | 6,620 |